Skip to content

News
Contact Us
Linkedin

Home
About Us
- Executive Team
Cycloset
Pipeline
- Cycloset for Pediatric T2DM Patients
- VS41157 for Pancreatic Cancer
Technologies
Therapeutic Areas
- Metabolic Diseases
- Immunological Disorders
Partners & Collaborators
Publications

Creators of Cycloset^®*, the first and only FDA approved sympatholytic dopamine D2 receptor agonist for the treatment of type 2 diabetes.
*See full prescribing info

Veroscience > News > Archives

Share
Print

Archives

July 26-27, 2019 Columbus, OH

Ohio River AACE 2019

www.heartindiabetes.com

Read More

July 12-14, 2019 Philadelphia, PA

Heart in Diabetes 2019

www.heartindiabetes.com

Read More

June 7-11, 2019 San Francisco, CA

ADA 2019

www.professional.diabetes.org/scientific-sessions

Read More

April 24-28, 2019 Los Angeles, CA

AACE 28th Annual Scientific & Clinical Congress

am.aace.com/index.asp

Read More

March 23-26, 2019 New Orleans, LA

ENDO 2019

www.endocrine.org/

Read More

July 13-15, 2018 Philadelphia, PA

Heart in Diabetes, 2nd Annual CME Conference

www.heartindiabetes.com

Read More

June 22-26, 2018 Orlando, FL

American Diabetes Association 78th Scientific Sessions

professional.diabetes.org/meeting/scientific-sessions/78th-scientific-sessions

Read More

June 9-13, 2017 San Diego, CA

American Diabetes Association 77th Scientific Sessions

professional.diabetes.org/meeting/scientific-sessions/77th-scientific-sessions

Read More

May 11-13, 2017 Anaheim, CA

Pri-Med West Annual Conference

www.pri-med.com/medical-conferences/2017/annual-conference-west.aspx

Read More

May 3-7, 2017 Austin, TX

AACE 26th Annual Scientific and Clinical Congress

aace2017.org/index.html

Read More

1 2 3 Next »

News
Archives

About Us
Executive Team

Cycloset
Mechanism of Action
Pre-Clinical Studies
Clinical Studies
U.S. Cycloset Patents

Pipeline
Cycloset for Pediatric T2DM Patients
VS41157 for Pancreatic Cancer

Technologies
Circadian Neuroendocrine Resetting Therapy (CNRT)
CNRT Overview Video References
Photo Immuno-Resetting Therapy for the Treatment of Cancer

Therapeutic Areas
Metabolic Diseases
Immunological Disorders

Partners & Collaborators
News
Publications
Contact Us
Site Map
Terms of Use

Website by Axxiem

© Copyright . All Right Reserved

By accessing our website or software provided by our third-party vendors, you consent to accept cookies, (including other identifiers). These include pieces of text that are stored on your computer or device. This site uses cookies and Google Analytics to improve navigation, minimize the need to reenter information previously entered on forms, personalize messages, and collect statistical information to improve site navigation and provide content of greatest interest to users.

Cookie settings ACCEPT

Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT